Partner Content Partner Content Why Does Quant-Led KOL Identification Fail In Growth Markets... When it comes to KOL identification mapping, there is no shortage of quant data around KOL and HCP activity out there.
Events Partner Content Transdermal and Microneedle Drug Delivery 2023 Transdermal and Microneedle Drug Delivery 2023
Events Partner Content 15th Annual Pre-Filled Syringes and Injectable Drug Devices ... The Future of Drug Delivery and Combination Products
Partner Content Partner Content The Role of Social Media in Healthcare Why Channel, Content, & Credibility are Key
Events Partner Content 4th Gene Therapy Analytical Development Summit 2022 The past twelve months have culminated in an unprecedented level of excitement, investment, and clinical progress within the gene therapy field.
Partner Content Partner Content KOL Identification Without KOL Mapping Among the infinite symposia, webinars, and white papers on this topic, “KOL identification” and “KOL mapping” can find themselves melting together in a gelatinous jargon
News FDA points to liver injury with Amgen's Tavneos The FDA has raised the pressure on Amgen to withdraw vasculitis drug Tavneos from the market with a report linking serious side effects to the drug.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.